Patent ID: 11964976
Assignee: KING FAISAL UNIVERSITY
Field: Pharmaceuticals (Chemistry)
Classification: CPC C  A | IPC A  C

Claim 3:
4. The compound of claim 1, or a pharmaceutically acceptable salt or stereoisomer thereof, wherein:
R is NH(CH2)3NR3R4 or NH(CH2)0-1Ar; and
Ar is optionally substituted with one, two, or three substituents independently selected from the group consisting of halogen, CN, C1-C6 alkyl, C1-C6 haloalkyl, C1-C6 cyanoalkyl, CH2NR1R2, C(O)R1, C(O)NR1R2, C(O)OR1, NR1R2, NHC(O)R1, NHC(O)NHR, NHC(O)OR1, NHS(O)2R1, NHS(O)2NHR1, OR1, OCH2C(O)R1, OCH2C(O)NR1R2, OCH2C(O)OR1, S(O)2NR1R2, C3-C6 cycloalkyl, C3-C6 halocycloalkyl, and C3-C6 cyanocycloalkyl.